(Family Features) Glaucoma, one of the leading causes of permanent blindness, often does its damage silently – with no noticeable symptoms – as vision is lost. Glaucoma affects an estimated 3 million Americans, but most people don’t know they have the condition until it’s revealed in an eye exam. Once vision is lost, it cannot be recovered. If left untreated, glaucoma can cause blindness. That’s why when it comes to detecting and treating glaucoma, the earlier, the better. What is Glaucoma? Glaucoma is an eye disease caused by increased pressure in the eye, which can damage the optic nerve and reduce vision, sometimes making objects look blurry or dark. Early on, most people don’t notice what’s happening, but as glaucoma progresses, you may notice some loss of peripheral vision. By this point, the disease has progressed significantly toward blindness, and treatment options may be limited. Diagnosing Glaucoma Regular eye exams, including specific glaucoma tests, are important for the early detection and diagnosis of glaucoma. If diagnosed early, an eye doctor can recommend treatment to manage glaucoma and help prevent vision loss. “Many patients are surprised to learn glaucoma often presents with no initial symptoms,” said Oluwatosin U. Smith, MD, glaucoma specialist and ophthalmologist at Glaucoma Associates of Texas. “That’s why routine, comprehensive eye exams are so vital. These screenings allow us to detect glaucoma in its earliest stages, often before any vision loss occurs. Early diagnosis and treatment are the cornerstone of effective glaucoma management and it empowers us to take proactive steps to protect your vision.” To check for glaucoma, your eye doctor tests your eye pressure, peripheral vision and overall eye health. The painless screening is the only way to accurately diagnose the condition and determine appropriate treatment. Traditional Glaucoma Treatment For decades, prescription eye drops have been the most common treatment to help lower eye pressure and slow the progression of the disease. Although prescription eye drops are commonly prescribed and generally effective at lowering eye pressure, they can cause challenges and unwanted side effects, including redness, irritation, burning, stinging or difficulty putting them in the eye. In addition, patients may find it difficult to remember to take their eye drops every day, and missing doses – even by accident – can put vision at risk by allowing eye pressure to rise unchecked. When prescription eye drops are unsuccessful at controlling eye pressure or managing glaucoma, an eye doctor may change treatment by prescribing additional prescription eye drops, which can make the challenges and inconveniences associated with prescription eye drops worse. Modern Glaucoma Management Takes a Proactive Approach Modern glaucoma management is evolving with a shift from reactive – that is, take prescription eye drops and “watch and wait” until glaucoma progresses before exploring alternative treatment – to proactive management. Taking a proactive approach to glaucoma treatment means choosing a minimally invasive procedure earlier in the treatment journey to help slow the progression of glaucoma and minimize vision loss while reducing the challenges of daily prescription eye drops. “The shift toward a more proactive approach represents a significant advancement in how we manage glaucoma,” Smith said. “Traditionally, we waited for vision loss before a procedural intervention. However, with modern minimally invasive procedures, we can now proactively lower eye pressure and protect the optic nerve much earlier. This approach helps us preserve our patients’ vision and quality of life for longer. I encourage anyone with a glaucoma diagnosis, or those with risk factors, to discuss proactive options with their ophthalmologist.”
Procedural pharmaceuticals, or drug delivery systems, may include tiny, FDA-approved implants that deliver medication continuously to help lower eye pressure and protect vision.
Micro-invasive, or minimally invasive, glaucoma surgery involves less-invasive procedures, devices (such as stents) and techniques with faster recovery times than traditional surgeries.
Laser treatment commonly involves a laser being aimed through a special lens onto the drainage system of the eye, triggering a natural change that helps fluid drain from the eye to lower pressure.
These treatments may be used in combination with prescription eye drops or on their own.
If you or a loved one has been diagnosed with glaucoma, visit livingwithglaucoma.com to learn more and help manage the condition. Photos courtesy of Shutterstock SOURCE:Glaukos
Diva Fam Inc. Announces Voluntary Recall of True Sea Moss “Sea Moss Gel Superfood” Products Due to Possible Health Risk
Diva Fam Inc. is recalling all True Sea Moss Sea Moss Gel Superfood flavors nationwide due to missing pH/temperature records and potential botulism risk.
Diva Fam Inc.. announced a voluntary recall of all lots and flavors of its True Sea Moss brand Sea Moss Gel Superfood due to a lack of required regulatory authorization and temperature monitoring records for pH-controlled food products, according to a company statement released January 9, 2026.
The company said the recall applies to products manufactured prior to January 9, 2026. The manufacture date (MFD) is indicated on the can lid in MM/YYYY format.
Why the products are being recalled
Diva Fam said the recall is related to missing required regulatory authorization and temperature monitoring records for certain pH-controlled food products. The company noted that pH-controlled foods that are not manufactured in accordance with applicable regulatory requirements may present a potential risk of microbial growth, including organisms that can produce toxins associated with botulism.
TrueSeaMoss Container
Botulism is a rare but serious illness that can affect the nervous system. Symptoms may include general weakness, dizziness, double vision, difficulty speaking or swallowing, and, in severe cases, difficulty breathing or muscle weakness.
Diva Fam said no illnesses or adverse health events have been reported in connection with the products subject to this recall to date.
Where the products were sold
The affected products were distributed nationwide through select retail locations, online via https://truеsеamоss.cоm/, and other distribution channels, according to the company.
Recalled products (all flavors, all lots)
The recall includes all flavors and sizes and batch numbers of True Sea Moss brand Sea Moss Gel Superfood packaged in 16 FL OZ (473 mL) glass jars, manufactured prior to January 9, 2026.True Sea Moss Packaging
Recalled flavors and UPCs
Flavor
UPC
Mango
5065006235875
Pineapple
5065006235288
Wildcrafted
5065006235073
Apple and Cinnamon
5065006235776
Elderberry
5065006235189
Passion Fruit
5061033691882
Blue Spirulina and Raspberry
5065006235813
Strawberry
5065006235271
Cherry
5061033691264
Mango and Pineapple
5065006235301
5 Blends in 1
5061033690052
Soursop
5061033691875
Lemon Pie
5061033691271
Orange
5061033692926
How the issue was identified
The company said the matter was identified during a California Department of Public Health inspection that raised questions regarding regulatory authorization and related production records for certain distributed products. Diva Fam said it is cooperating fully with regulatory authorities and initiated the voluntary recall to ensure regulatory alignment.
The company said the recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
What consumers should do
Discontinue use of the affected product.
Follow the instructions provided by the place of purchase regarding product return or disposal.
Contact the company for additional information (details below).
Consumer and media contact
Consumers seeking additional information may contact:
Hal Machina is a passionate writer, blogger, and self-proclaimed journalist who explores the intersection of science, tech, and futurism. Join him on a journey into innovative ideas and groundbreaking discoveries! View all postsjournalist
Swisse Launches Glam Bites: Zero-Sugar Beauty Gummies Designed for Busy Routines
Swisse launches Glam Bites: delicious beauty gummies with zero sugar, no sugar alcohols, and no artificial flavors, colors, or sweeteners—designed to support beauty from within.
Swisse Launches Glam Bites: Zero-Sugar Beauty Gummies Designed for Busy Routines
Swisse, the premium supplement brand under Health & Happiness (H&H) Group and a Certified B Corp, is kicking off 2026 with a new way to support “beauty from within.” The company just introduced Swisse Beauty Glam Bites, a line of zero-sugar beauty gummies made with science-backed ingredients—without the usual “junk” found in many gummy supplements. Positioned for today’s always-on lifestyle, Glam Bites aims to make daily self-care feel less like another task and more like a quick, enjoyable habit: bite, nourish, and glow.
What makes Glam Bites different?
Gummy supplements are popular, but they often come with tradeoffs—added sugars, sugar alcohols, artificial flavors, or ingredients that don’t align with cleaner-label preferences. Swisse is leaning into the opposite approach. According to the company, Glam Bites are crafted with:
Zero sugar
No sugar alcohols
No artificial flavors, colors, or sweeteners
Gluten-free
Free from major allergens (milk, eggs, fish, crustacean shellfish, peanuts, wheat, soybeans, sesame)
That “clean but still tasty” promise is a big part of the launch—especially as more shoppers look for supplements that fit into wellness routines without feeling like a compromise.
A beauty routine that starts from the inside
Swisse is framing Glam Bites as a simple daily add-on that supports skin, hair, and nails through targeted micronutrients. Leading dietitian Dana A. White highlighted the brand’s approach in the announcement, noting that Glam Bites deliver “powerful, science-driven beauty benefits” through a precisely balanced blend of nutrients—while keeping the formula free from artificial colors, flavors, and sweeteners.
The Glam Bites lineup (available now)
Swisse launched Glam Bites in three formulas, each with its own ingredient blend and naturally flavored profile.
1) Hair Skin Nails Glam Bites
Price/Count: $19.99 (60 count)
Key ingredients: Biotin, Zinc, Bamboo Extract
What it supports: Stronger hair and nails, plus skin firmness and elasticity*
Flavor: Blood orange (naturally flavored)
2) Glow Skin Glam Bites
Price/Count: $24.99 (60 count)
Key ingredients: Hyaluronic Acid, Vitamins C & E, Sea Moss, Hydrolyzed Marine Collagen Peptides
What it supports: Collagen production, improved elasticity, and a stronger skin barrier*
Flavor: Blueberry lavender (naturally flavored)
3) Skin Defense Glam Bites
Price/Count: $24.99 (60 count)
Key ingredients: Astaxanthin, L-Glutathione, Green Tea Extract
What it supports: Healthy aging, even skin tone, and antioxidant protection against environmental stressors*
Flavor: Raspberry green tea (naturally flavored)
Why gummies—and why now?
Swisse is launching Glam Bites at a time when gummies are increasingly becoming the preferred supplement format for younger consumers. The company cited research showing:
45% of Gen Z and 31% of millennials favor gummy supplements.
74% of U.S. personal care buyers agree that skin health reflects overall health.
In other words: the market is shifting toward convenience, better taste, and wellness products that connect beauty with whole-body health.
A global wellness brand expanding its portfolio
Swisse was founded in Australia in 1969 and has grown into a global wellness name known for premium supplements made with ingredients backed by scientific research and produced under world-class manufacturing standards. With Glam Bites, the brand is clearly betting on a “cleaner gummy” future—one that fits modern routines and modern label expectations.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Our Lifestyle section on STM Daily News is a hub of inspiration and practical information, offering a range of articles that touch on various aspects of daily life. From tips on family finances to guides for maintaining health and wellness, we strive to empower our readers with knowledge and resources to enhance their lifestyles. Whether you’re seeking outdoor activity ideas, fashion trends, or travel recommendations, our lifestyle section has got you covered. Visit us today at https://stmdailynews.com/category/lifestyle/ and embark on a journey of discovery and self-improvement.
How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker
C-reactive protein (CRP) is a key inflammation marker that can predict heart attack and stroke risk—often better than LDL cholesterol. Here’s why it matters.
C-reactive protein is created by the liver in response to infections, tissue damage, chronic inflammatory states from conditions like autoimmune diseases, and metabolic disturbances like obesity and diabetes. Essentially, it is a marker of inflammation – meaning immune system activation – in the body. C-reactive protein can be easily measured with blood work at the doctor’s office. A low C-reactive protein level – under 1 milligram per deciliter – signifies minimal inflammation in the body, which is protective against heart disease. An elevated C-reactive protein level of greater than 3 milligrams per deciliter, signifies increased levels of inflammation and thus increased risk for heart disease. About 52% of Americans have an elevated level of C-reactive protein in their blood. Research shows that C-reactive protein is a better predictive marker for heart attacks and strokes than “bad,” or LDL cholesterol, short for low-density lipoprotein, as well as another commonly measured genetically inherited biomarker called lipoprotein(a). One study found that C-reactive protein can predict heart disease just as well as blood pressure can.
Why does inflammation matter in heart disease?
Inflammation plays a crucial role at every stage in the development and buildup of fatty plaque in the arteries, which causes a condition called atherosclerosis that can lead to heart attacks and strokes. From the moment a blood vessel is damaged, be it from high blood sugar or cigarette smoke, immune cells immediately infiltrate the area. Those immune cells subsequently engulf cholesterol particles that are typically floating around in the blood stream to form a fatty plaque that resides in the wall of the vessel. This process continues for decades until eventually, one day, immune mediators rupture the cap that encloses the plaque. This triggers the formation of a blood clot that obstructs blood flow, starves the surrounding tissues of oxygen and ultimately causes a heart attack or stroke. Hence, cholesterol is only part of the story; it is, in fact, the immune system that facilitates each step in the processes that drive heart disease.Fatty plaque buildup in the arteries causes a blockage that starves tissues of oxygen and can lead to a heart attack or stroke.wildpixel/iStock via Getty Images Plus
Does cholesterol still matter for heart disease risk?
Though cholesterol may not be the most important predictor of risk for heart disease, it does remain highly relevant. However, it’s not just the amount of cholesterol – or more specifically the amount of bad, or LDL, cholesterol – that matters. Two people with the same cholesterol level don’t necessarily have the same risk for heart disease. This is because risk is determined more so by the number of particles that the bad cholesterol is packaged into, as opposed to the total mass of bad cholesterol that’s floating around. More particles means higher risk. That is why a blood test known as apolipoprotein B, which measures the number of cholesterol particles, is a better predictor of risk for heart disease than measurements of total amounts of bad cholesterol. Like cholesterol and C-reactive protein, apolipoprotein B is also influenced by lifestyle factors like exercise, weight loss and diet. Nutrients like fiber, nuts and omega-3 fatty acids are associated with a decreased number of cholesterol particles, while increased sugar intake is associated with a larger number of cholesterol particles. Furthermore, lipoprotein(a), a protein that lives in the wall surrounding cholesterol particles, is another marker that can predict heart disease more accurately than cholesterol levels. This is because the presence of lipoprotein(a) makes cholesterol particles sticky, so to speak, and thus more likely to get trapped in an atherosclerotic plaque. However, unlike other risk factors, lipoprotein(a) levels are purely genetic, thus not influenced by lifestyle, and need only be measured once in a lifetime.
What’s the best way to prevent heart disease?
Ultimately, heart disease is the product of many risk factors and their interactions over a lifetime. Therefore, preventing heart disease is way more complicated than simply eating a cholesterol-free diet, as once thought. Knowing your LDL cholesterol level alongside your C-reactive protein, apolipoprotein B and lipoprotein (a) levels paints a comprehensive picture of risk that can hopefully help motivate long-term commitment to the fundamentals of heart disease prevention. These include eating well, exercising consistently, getting adequate sleep, managing stress productively, maintaining healthy weight and, if applicable, quitting smoking.Mary J. Scourboutakos, Adjunct Assistant Professor in Family and Community Medicine, Macon & Joan Brock Virginia Health Sciences at Old Dominion University This article is republished from The Conversation under a Creative Commons license. Read the original article.
Modern Glaucoma Management Takes a Proactive Approach Modern glaucoma management is evolving with a shift from reactive – that is, take prescription eye drops and “watch and wait” until glaucoma progresses before exploring alternative treatment – to proactive management. Taking a proactive approach to glaucoma treatment means choosing a minimally invasive procedure earlier in the treatment journey to help slow the progression of glaucoma and minimize vision loss while reducing the challenges of daily prescription eye drops. “The shift toward a more proactive approach represents a significant advancement in how we manage glaucoma,” Smith said. “Traditionally, we waited for vision loss before a procedural intervention. However, with modern minimally invasive procedures, we can now proactively lower eye pressure and protect the optic nerve much earlier. This approach helps us preserve our patients’ vision and quality of life for longer. I encourage anyone with a glaucoma diagnosis, or those with risk factors, to discuss proactive options with their ophthalmologist.”
Mary J. Scourboutakos, Adjunct Assistant Professor in Family and Community Medicine, Macon & Joan Brock Virginia Health Sciences at Old Dominion University This article is republished from The Conversation under a Creative Commons license. Read the original article.
